Biopharmaceuticals: recent trends and likely directions: Recent approvals and likely directions

Research output: Contribution to journalArticlepeer-review

Abstract

Some 160 biopharmaceuticals have now gained medical approval and several hundred are in the pipeline. Most are protein-based, although two nucleic acid-based products are now on the US/European market. An increasing proportion of approvals are engineered in some way and advances in alternative production systems and delivery methods will also likely impact upon the approvals profile over the remainder of this decade.

Original languageEnglish (Ireland)
Pages (from-to)553-558
Number of pages6
JournalTrends in Biotechnology
Volume23
Issue number11
DOIs
Publication statusPublished - Nov 2005

Fingerprint

Dive into the research topics of 'Biopharmaceuticals: recent trends and likely directions: Recent approvals and likely directions'. Together they form a unique fingerprint.

Cite this